Effects of SGLT2 inhibitor dapagliflozin in patients with type 2 diabetes on skeletal muscle cellular metabolism
Author:
Funder
AstraZeneca
Maastricht Universitair Medisch Centrum
Publisher
Elsevier BV
Subject
Cell Biology,Molecular Biology
Reference54 articles.
1. Dapagliflozin in patients with chronic kidney disease;Heerspink;The New England Journal of Medicine,2020
2. Dapagliflozin in patients with heart failure and reduced Ejection fraction;McMurray;The New England Journal of Medicine,2019
3. Dapagliflozin maintains glycaemic control while reducing weight and body fat mass over 2 years in patients with type 2 diabetes mellitus inadequately controlled on metformin;Bolinder;Diabetes, Obesity and Metabolism,2014
4. Quantitative PCR tissue expression profiling of the human SGLT2 gene and related family members;Chen;Diabetes Therapy,2010
5. Differential in vitro effects of SGLT2 inhibitors on mitochondrial oxidative phosphorylation, glucose uptake and Cell Metabolismism;Zugner;International Journal of Molecular Sciences,2022
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Cardiovascular benefits of SGLT2 inhibitors and GLP-1 receptor agonists through effects on mitochondrial function and oxidative stress;Free Radical Biology and Medicine;2024-03
2. The antidiabetic SGLT2 inhibitor canagliflozin reduces mitochondrial metabolism in a model of skeletal muscle insulin resistance;Diabetic Medicine;2023-12-23
3. SGLT2 inhibitors in Patients Admitted for Acute Heart Failure: The Earlier the Better;The American Journal of Cardiology;2023-12
4. Efficacy and Safety of Enavogliflozin versus Dapagliflozin as Add-on to Metformin in Patients with Type 2 Diabetes Mellitus: A 24-Week, Double-Blind, Randomized Trial;Diabetes & Metabolism Journal;2023-11-30
5. Exercise mitigates Dapagliflozin-induced skeletal muscle atrophy in STZ-induced diabetic rats;Diabetology & Metabolic Syndrome;2023-07-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3